Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny
Jul 20, 2025
by Prosper Junior Bakiny
Does This Move Make Merck Stock a Buy?
Jul 15, 2025
by Prosper Junior Bakiny
1 Unstoppable Growth Stock to Buy With $3,000
Jul 14, 2025
by Prosper Junior Bakiny
2 Beaten-Down Stocks That Could Bounce Back
Jul 13, 2025
by Prosper Junior Bakiny
Should You Buy Netflix Stock Before July 17?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.